Immuneering (IMRX) Accumulated Depreciation & Amortization: 2020-2024
Historic Accumulated Depreciation & Amortization for Immuneering (IMRX) over the last 4 years, with Dec 2024 value amounting to $86,116.
- Immuneering's Accumulated Depreciation & Amortization fell 4.05% to $86,116 in Q4 2024 from the same period last year, while for Dec 2024 it was $355,807, marking a year-over-year increase of 10.22%. This contributed to the annual value of $355,807 for FY2024, which is 10.22% up from last year.
- Immuneering's Accumulated Depreciation & Amortization amounted to $86,116 in Q4 2024, which was down 3.18% from $88,949 recorded in Q3 2024.
- Immuneering's 5-year Accumulated Depreciation & Amortization high stood at $418,337 for Q4 2022, and its period low was $47,703 during Q2 2022.
- For the 3-year period, Immuneering's Accumulated Depreciation & Amortization averaged around $119,555, with its median value being $87,532 (2024).
- Per our database at Business Quant, Immuneering's Accumulated Depreciation & Amortization skyrocketed by 140.12% in 2022 and then slumped by 78.55% in 2023.
- Quarterly analysis of 5 years shows Immuneering's Accumulated Depreciation & Amortization stood at $128,752 in 2020, then surged by 35.31% to $174,219 in 2021, then spiked by 140.12% to $418,337 in 2022, then plummeted by 78.55% to $89,754 in 2023, then fell by 4.05% to $86,116 in 2024.
- Its Accumulated Depreciation & Amortization stands at $86,116 for Q4 2024, versus $88,949 for Q3 2024 and $90,533 for Q2 2024.